keyword
https://read.qxmd.com/read/38577340/malignant-transformation-of-primary-ameloblastoma-of-skull-case-report-and-review-of-current-literature
#1
Haitong Xu, Jialiang Tan, Dongxiang Fu
BACKGROUND: Since 1964, there has been a scarcity of reported cases of primary ameloblastoma (AM) or ameloblastic carcinoma (AMCa) of the skull. The clinical presentation and distinctive features of this uncommon condition at specific anatomical sites remain unclear. We report a case of malignant transformation of a primary AM of the skull situated in the frontal-temporal-parietal region and highlight its similarities to other cases reported in the literature. CLINICAL PRESENTATION: A 53-year-old female patient presented with a 20-day history of headaches and bilateral lower limb weakness for 10 days...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38558693/skull-metastasis-with-orbital-invasion-as-a-primary-manifestation-of-hepatocellular-carcinoma
#2
Samer Jumean, Shatha Elemian, Hamid S Shaaban, Gunwant Guron
Hepatocellular carcinoma (HCC) is a common worldwide cancer with a poor prognosis despite treatment advancements. Patients typically exhibit signs and symptoms pertaining to the liver. Extrahepatic metastasis of HCC is documented to be as low as 5% of cases. Bone metastasis ranks third following lungs and regional lymph nodes. The typical locations for bone metastasis include the vertebral column, pelvis, femora, and ribs, with skull metastasis, being reported in less than 1.6% of cases. Herein, we describe a case of HCC presenting with skull metastases and orbital invasion as the initial manifestation...
February 2024: Curēus
https://read.qxmd.com/read/38506422/sebaceous-carcinoma-of-the-middle-ear-a-case-report
#3
Michael S Castle, Shalini Shah, Rachel E Roditi, Margaret L Compton, Ellen J Giampoli, Paul O Dutcher
Here we present the first case of sebaceous carcinoma of the middle ear. We discuss the treatment course and post treatment results after 11 years of follow up. We further summarize the available literature of sebaceous carcinoma of the temporal bone, which prior to this case was exclusively limited to the external auditory canal. Laryngoscope, 2024.
March 20, 2024: Laryngoscope
https://read.qxmd.com/read/38457191/deletion-of-concurrent-chemotherapy-on-the-basis-of-sequential-chemoradiotherapy-for-non-metastatic-stage-t4-nasopharyngeal-carcinoma-in-imrt-era
#4
JOURNAL ARTICLE
Yuming Zheng, Fen Xue, Dan Ou, Xiaoshuang Niu, Chaosu Hu, Xiayun He
PURPOSE: Intensity-modulated radiotherapy (IMRT) combined with concurrent chemotherapy is deemed as the mainstay treatment in locoregionally advanced nasopharyngeal carcinoma (NPC). Nevertheless, the tolerance of severe acute toxicity of concurrent chemotherapy was unsatisfied. In addition, T4 is the predicting factor of poor prognosis for NPC patients. In this retrospective analysis, the long-term outcomes IMRT combined by induction chemotherapy deleting concurrent chemotherapy with or without adjuvant chemotherapy for T4 non-metastatic NPC were analyzed...
February 2024: Cancer Medicine
https://read.qxmd.com/read/38379276/expression-of-egfr-and-p16-in-squamous-cell-carcinoma-of-external-auditory-canal
#5
JOURNAL ARTICLE
Yasuyuki Kajimoto, Hirotaka Shinomiya, Natsumi Uehara, Masanori Teshima, Takeshi Fujita, Akinobu Kakigi, Yoshinori Imamura, Naomi Kiyota, Daisuke Miyawaki, Ryohei Sasaki, Hidehito Kimura, Ken-Ichi Nibu
The expression of EGFR and p16 in the external auditory canal squamous cell carcinoma (EACSCC) and their impacts on oncological outcomes were not well studied. Seventeen-one consecutive patients who were treated for EACSCC at Kobe University Hospital from 1995 to 2018 were enrolled in this study. The expression of EGFR, and p16 were evaluated and their impacts on oncological outcomes were statistically analyzed. Positive expression of EGFR was observed in 62 patients (87%). Strong positive expression of p16 were observed in 18 patients (32...
January 31, 2024: Kobe Journal of Medical Sciences
https://read.qxmd.com/read/38362177/treatment-outcome-and-prognostic-factors-of-external-auditory-canal-squamous-cell-carcinoma-a-retrospective-study-in-a-tertiary-center
#6
JOURNAL ARTICLE
Yi-Ting Huang, Jiunn-Liang Wu, Wen-Yuan Chao, Wei-Ting Lee
OBJECTIVE: Squamous cell carcinoma (SCC) of the external auditory canal (EAC) is a rare malignancy with various treatment strategies and outcomes. The purpose of this study was to evaluate the clinical characteristics and survival outcomes and identify prognostic factors in patients with SCC of EAC. METHODS: Twenty-one patients with SCC of EAC treated in a single tertiary center between 2009 and 2021 were retrospectively reviewed and analyzed. The modified Pittsburgh classification system was applied for staging...
February 2024: Laryngoscope Investigative Otolaryngology
https://read.qxmd.com/read/38360789/sinonasal-schneiderian-tumors-in-the-temporal-bone-case-series-and-systematic-review
#7
JOURNAL ARTICLE
Francis Deng, Peter M Sadow, Nabeeha Khan, Xin Wu, Ivan H El-Sayed, David H Jung, Christine M Glastonbury, Amy F Juliano
BACKGROUND: Neoplasms derived from the sinonasal epithelium are a rare finding in the temporal bone, and their origins are controversial. PURPOSE: To review the characteristics of sinonasal epithelial (previously known as Schneiderian) tumors occurring in the temporal bone. DATA SOURCE: This was a 2-center case series and systematic review of MEDLINE, EMBASE, and the Web of Science through May 2021. STUDY SELECTION: Patients with clinicopathologic evidence of temporal bone involvement by neoplasms of sinonasal epithelial origin were selected, with or without a history of prior primary sinonasal epithelial tumors...
February 15, 2024: AJNR. American Journal of Neuroradiology
https://read.qxmd.com/read/38343349/squamous-cell-carcinoma-of-the-temporal-bone-the-impact-of-local-control-on-survival
#8
REVIEW
Antoine Dubray-Vautrin, Benjamin Vérillaud, Philippe Herman, Romain Kania
BACKGROUND: Squamous cell carcinoma (SCC) of the temporal bone (TB) is a rare pathology originating from the external auditory canal (EAC). Surgery remains the gold standard to achieve local control.Aims/Objectives:The aim of this study was to evaluate overall survival (OS) and disease-free survival (DFS) after surgery of the SCC of EAC. MATERIAL AND METHODS: A retrospective chart review in a tertiary referral center included 26 patients: 23 were operated with lateral temporal bone resection (LTBR, n  = 10) and extended temporal bone resection (ETBR, n  = 13)...
February 12, 2024: Acta Oto-laryngologica
https://read.qxmd.com/read/38341629/survival-outcomes-of-temporal-bone-squamous-cell-carcinoma-a-systematic-review-and-meta-analysis
#9
REVIEW
Krystelle Sioufi, Aaron David Haynes, Paul W Gidley, Anastasios Maniakas, Dianna Roberts, Marc-Elie Nader
OBJECTIVE: Temporal bone squamous cell carcinoma (TBSCC) is a rare malignancy with poor prognosis, and optimal treatment for advanced cases is uncertain. Our systematic literature review aimed to assess 5-year survival outcomes for advanced TBSCC across different treatment modalities. DATA SOURCES: EMBASE, Medline, PubMed, and Web of Science. REVIEW METHODS: A systematic literature review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for articles published between January 1989 and June 2023...
February 11, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38193562/temporal-bone-management-in-external-and-middle-ear-carcinoma
#10
JOURNAL ARTICLE
Shravan Gowrishankar, Daniele Borsetto, John Marinelli, Ben Panizza
PURPOSE OF REVIEW: The purpose of this review is to outline the temporal bone management of external and middle ear carcinoma. The review will outline the current evidence involved in deciding which surgical approach to take, as well as new advances in auditory rehabilitation and immunotherapy. RECENT FINDINGS: Traditional surgical approaches include lateral temporal bone resection, subtotal temporal bone resection and total temporal bone resection. They can also involve parotidectomy and neck dissection depending on extension of disease into these areas...
January 9, 2024: Current Opinion in Otolaryngology & Head and Neck Surgery
https://read.qxmd.com/read/38161557/unusual-presentation-of-prostate-cancer-a-case-report
#11
Mariana Pinto, José Diez Carvalho, Gonçalo Magalhães, Sílvia Gomes, Filipa Figueiredo
Prostate cancer is the second-most common malignancy in males. Despite more frequently metastasizing to the bone, regional lymph nodes, and liver, the brain can also be affected. These metastases can simulate meningiomas, making the diagnosis more difficult. Here, we report the case of a 62-year-old male with a sudden onset of confusion and dysarthria with spontaneous resolution but amnesia for the event. On a neurological exam, the patient had left exophthalmos and palpebral ptosis. He was referred to the emergency room, where he underwent a cranioencephalic CT, which revealed a left anterior temporal lesion with adjacent edema suggestive of meningioma, later confirmed by an MRI...
December 2023: Curēus
https://read.qxmd.com/read/38130268/role-of-the-otologist-neurotologist-in-managing-auricular-and-periauricular-cutaneous-malignancies-a-10-year-otologic-oncology-experience
#12
JOURNAL ARTICLE
Tirth R Patel, Andrew D P Prince, William J Benjamin, Gregory J Basura
OBJECTIVE: Auricular/periauricular cutaneous malignancies can be challenging to manage surgically due to the complex anatomy of the region. Otologists/neurotologists have unique skillsets that are well-suited to surgically treat these patients. We aim to highlight the role of otologists and neurotologists in providing surgical care of patients with auricular and periauricular malignancies by describing the experience of a single fellowship-trained neurotologist over a 10-year period. METHODS: Retrospective chart review of 387 patients with auricular and periauricular malignancy treated by a single neurotologist between 2012 and 2022 was completed...
December 2023: Laryngoscope Investigative Otolaryngology
https://read.qxmd.com/read/38122866/unraveling-the-natural-history-of-good-s-syndrome-a-progressive-combined-adult-immunodeficiency
#13
JOURNAL ARTICLE
Aunonna Kabir, Vanessa Polito, Christos M Tsoukas
BACKGROUND: Good's syndrome (GS) is a rare immune deficiency described almost six decades ago. Despite numerous published individual case reports and data collected in cross-sectional studies of small cohorts, the natural history and long-term outcomes of this disease remain unknown. OBJECTIVE: We aimed to determine the clinical and laboratory evolution of 8 adults diagnosed with GS and consecutively evaluated between 1983-2023. METHODS: In this prospective, longitudinal cohort study, newly diagnosed GS patients were followed through repeated measures of clinical, immune, and hematologic changes, as well as targeted genetic screening...
December 18, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38055638/revealing-chronic-disease-progression-patterns-using-gaussian-process-for-stage-inference
#14
JOURNAL ARTICLE
Yanfei Wang, Weiling Zhao, Angela Ross, Lei You, Hongyu Wang, Xiaobo Zhou
OBJECTIVE: The early stages of chronic disease typically progress slowly, so symptoms are usually only noticed until the disease is advanced. Slow progression and heterogeneous manifestations make it challenging to model the transition from normal to disease status. As patient conditions are only observed at discrete timestamps with varying intervals, an incomplete understanding of disease progression and heterogeneity affects clinical practice and drug development. MATERIALS AND METHODS: We developed the Gaussian Process for Stage Inference (GPSI) approach to uncover chronic disease progression patterns and assess the dynamic contribution of clinical features...
December 5, 2023: Journal of the American Medical Informatics Association: JAMIA
https://read.qxmd.com/read/37811176/ct-and-mri-in-the-preoperative-planning-of-balloon-dilation-of-the-eustachian-tube-literature-review
#15
REVIEW
Maria Borshchenko, Kseniya Eremeeva, Valery Svistushkin
Balloon dilatation of the Eustachian tube (BET) is a surgical treatment method for Eustachian tube dysfunction (ETD), which relieves the symptoms in the majority of cases. However, there are potential intraoperative risks associated with BET; the decision-making process with regard to indications for BET is not standardized up to date. The objective of this study was to review the role of computed tomography (CT) and magnetic resonance imaging (MRI) in the preoperative planning of BET. The literature review is based on a database search performed in August 2022...
October 2023: Indian Journal of Radiology & Imaging
https://read.qxmd.com/read/37737376/patterns-of-spread-and-anatomical-prognostic-factors-of-pre-auricular-cutaneous-squamous-cell-carcinoma-extending-to-the-temporal-bone
#16
JOURNAL ARTICLE
Michael J C Schachtel, Mitesh Gandhi, James J Bowman, Benedict J Panizza
BACKGROUND: Improvements can be made in the management and staging of advanced pre-auricular cutaneous squamous cell carcinoma (cSCC). We aimed to analyze radiological patterns of spread and clinico-anatomical prognostic factors. METHODS: Retrospective review of 54 patients with pre-auricular cSCC (cutaneous/nodal) who underwent temporal bone resection with curative intent. RESULTS: Involvement of the cartilaginous external auditory canal (EAC) (79...
November 2023: Head & Neck
https://read.qxmd.com/read/37686564/impact-of-positive-margin-resection-of-external-auditory-canal-squamous-cell-carcinoma
#17
JOURNAL ARTICLE
Noritaka Komune, Ryosuke Kuga, Takahiro Hongo, Daisuke Kuga, Kuniaki Sato, Takashi Nakagawa
BACKGROUND: Positive-margin resection of external auditory canal squamous cell carcinoma (EAC-SCC) is still a major cause of recurrence. The aim of this study is to examine the clinical impact of positive-margin resection of EAC-SCCs. METHODS: We retrospectively reviewed 40 surgical cases with en bloc temporal bone resection of EAC-SCC at a tertiary referral center from October 2016 to March 2022. RESULTS: Two-year disease-specific, overall, and disease-free survival rates for all 40 cases reviewed were 85...
August 27, 2023: Cancers
https://read.qxmd.com/read/37636674/systematic-review-of-management-and-survival-outcome-of-parotid-cancers-with-lateral-skull-base-invasion
#18
JOURNAL ARTICLE
Pietro De Luca, Arianna Di Stadio, Pasquale Marra, Vito Colacurcio, Alfonso Scarpa, Filippo Ricciardiello, Massimo Ralli, Francesco Longo, Giovanni Salzano, Marco de Vincentiis, Giorgio Iaconetta, Francesco Antonio Salzano, Angelo Camaioni
Lateral skull base involvement from parotid cancers is a rare condition and is considered a poor prognostic indicator. The aim of this study was to systematically review the literature of parotid tumors with temporal bone invasion to analyze the survival outcome. A systematic literature review was performed in August 2022, without time limits, and 289 patients affected by parotid gland cancers and lateral skull base involvement were included. The most common symptoms in parotid tumors at the onset were indolent mass, facial weakness, pain, and hearing loss; the chi-square value is 23...
September 2023: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/37621272/treatment-outcomes-of-the-external-auditory-canal-and-temporal-bone-malignancy-with-dura-invasion
#19
JOURNAL ARTICLE
Yun Ji Lee, In Seong Jeong, Jong Woo Chung
OBJECTIVES: This study aimed to evaluate the characteristics and surgical outcomes of patients with external auditory canal (EAC) and temporal bone (TB) malignancy with dura invasion. METHODS: The medical records of patients with EAC and TB malignancy with dura invasion were retrospectively reviewed. Survival outcomes (overall survival [OS], disease-specific survival [DSS], recurrence-free survival [RFS], and distant metastasis-free survival [DMFS]) were analyzed using the Kaplan-Meier method...
August 2023: Laryngoscope Investigative Otolaryngology
https://read.qxmd.com/read/37503962/oncological-outcomes-of-concurrent-chemoradiotherapy-with-docetaxel-cisplatin-and-5-fluorouracil-for-locally-advanced-squamous-cell-carcinoma-of-the-external-auditory-canal-a-single-center-study
#20
JOURNAL ARTICLE
Akihiro Yamada, Hirotaka Shinomiya, Natsumi Uehara, Keisuke Iritani, Shun Tatehara, Tatsuya Furukawa, Masanori Teshima, Daisuke Miyawaki, Takeshi Fujita, Akinobu Kakigi, Naomi Kiyota, Ryohei Sasaki, Ken-Ichi Nibu
BACKGROUND: Squamous cell carcinoma of the external auditory canal (EACSCC) is a rare condition. However, a standard treatment has not yet been established. We retrospectively evaluated the efficacy, adverse events, and feasibility of TPF-CCRT (concomitant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil) in patients with advanced EACSCC. METHODS: Thirty-five consecutive patients with advanced EACSCC (T3, T4) initially treated with TPF-CCRT at Kobe University Hospital were included...
July 28, 2023: Head & Neck
keyword
keyword
93199
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.